Consistent with the HNSCC cell lines, everolimus reduced levels of HIF-1α, VEGF-A and VEGF-C in both HMEC-1 (Figure 5B) and HMEC-1A (Figure 5E) cells. This evidence concerns the gene HIF1A and head and neck squamous cell carcinoma.